Regeneron (REGN) volatility flat into Amgen (AMGM) court victory
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Jefferies Cuts Price Target on Regeneron (REGN) Following District Court Ruling
January 6, 2017 9:28 AM ESTJefferies maintained a Hold rating on Regeneron Pharma (NASDAQ: REGN), and cut the price target to $349.00 (from $394.00), following a decision by the District Court of Delaware. Judge Sue Robinson at the District Court of Delaware ruled in favor of Amgen (NASDAQ:... More
